Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer

Clinical trial NCT00408499 · COMPLETED

Trial details

NCT number: NCT00408499
Sponsor: University of California, Davis
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2006-08-01
Primary completion: 2009-04-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.